Work

Supplementary Figure S1 from A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma

Year: 2024
Type: supplementary-materials
Abstract: Treatment-Free Survival in Advanced Renal Cell Carcinoma Trials Evaluating Immuno-Oncology-VEGF TKI Combinations: Sunitinib Group
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4401205502
Cites:
Cited by:
Related to: 10